Q90643
Gene name |
IRF3 |
Protein name |
Interferon regulatory factor 3 |
Names |
IRF-3 |
Species |
Gallus gallus (Chicken) |
KEGG Pathway |
gga:396330 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
2-138 (N-terminal DNA-binding domain);459-491 (Signal response domain) |
Relief mechanism |
PTM |
Assay |
|
Accessory elements
No accessory elements
References
- Sathish N et al. (2011) "Mechanisms of autoinhibition of IRF-7 and a probable model for inactivation of IRF-7 by Kaposi's sarcoma-associated herpesvirus protein ORF45", The Journal of biological chemistry, 286, 746-56
- Ning S et al. (2011) "IRF7: activation, regulation, modification and function", Genes and immunity, 12, 399-414
- Lin R et al. (1999) "Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains", Molecular and cellular biology, 19, 2465-74
- Panne D et al. (2007) "An atomic model of the interferon-beta enhanceosome", Cell, 129, 1111-23
Autoinhibited structure

Activated structure

1 structures for Q90643
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q90643-F1 | Predicted | AlphaFoldDB |
No variants for Q90643
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for Q90643 |
No associated diseases with Q90643
7 regional properties for Q90643
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Protein kinase domain | 652 - 908 | IPR000719 |
active_site | Serine/threonine-protein kinase, active site | 769 - 781 | IPR008271 |
binding_site | Protein kinase, ATP binding site | 658 - 681 | IPR017441 |
domain | MAP3K, TRAFs-binding domain | 136 - 514 | IPR025136 |
domain | MAP3K, PH domain | 527 - 624 | IPR043969 |
domain | MAP3K, deoxyribohydrolase domain | 86 - 121 | IPR046872 |
domain | MAP3K, HisK-N-like globin domain | 1003 - 1134 | IPR046873 |
Functions
2 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
2 GO annotations of molecular function
Name | Definition |
---|---|
DNA-binding transcription factor activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. |
RNA polymerase II cis-regulatory region sequence-specific DNA binding | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. |
7 GO annotations of biological process
Name | Definition |
---|---|
defense response to virus | Reactions triggered in response to the presence of a virus that act to protect the cell or organism. |
immune system process | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
positive regulation of DNA-templated transcription | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
positive regulation of type I interferon production | Any process that activates or increases the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families. |
regulation of transcription by RNA polymerase II | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. |
toll-like receptor signaling pathway | The series of molecular signals initiated by a ligand binding to a toll-like receptor of a target cell. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate an innate immune response. |
TRIF-dependent toll-like receptor signaling pathway | The series of molecular signals initiated by a ligand binding to a toll-like receptor where the TRIF adaptor mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate an innate immune response. |
4 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q90871 | IRF8 | Interferon regulatory factor 8 | Gallus gallus (Chicken) | PR |
Q98925 | IRF2 | Interferon regulatory factor 2 | Gallus gallus (Chicken) | PR |
Q92985 | IRF7 | Interferon regulatory factor 7 | Homo sapiens (Human) | EV |
P70434 | Irf7 | Interferon regulatory factor 7 | Mus musculus (Mouse) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MAALDSEGDA | QKLRFGPWLL | NAVSSGLYRG | LCWIDPDRRI | FRIPWKHNAR | KDVTSSDVEI |
70 | 80 | 90 | 100 | 110 | 120 |
FKAWAKASGR | YEGNAEDPAK | WKTNFRCALR | STHMFMLLED | RSKCNDDPHK | VYAVASGVPN |
130 | 140 | 150 | 160 | 170 | 180 |
DRGSGGPVAG | ALQQQPQLLL | NHHDLALENT | PTDSTEGVAA | AALTQVDLDL | LQSVLQHCNI |
190 | 200 | 210 | 220 | 230 | 240 |
SALGSQPTLW | AHTGDALPED | ALLLPGQDGC | LPGPQFQDWR | QLEEPLLLGN | QPLTGGGCGQ |
250 | 260 | 270 | 280 | 290 | 300 |
DGAGALPVSE | ECAIPAPSPA | EELLFQSANP | APPPPAGDIG | GLPPLLDITI | YYRGKMVYQE |
310 | 320 | 330 | 340 | 350 | 360 |
QVDDSRCVLA | YQPLDPAVAE | QRLVLFPSPA | SLPDPRQRRY | TEDLLEVAGL | RLEQRAGQLL |
370 | 380 | 390 | 400 | 410 | 420 |
ATRLKKCKVF | WALSQQLEGG | EPPLNLLHRD | QETTIFDFRV | FCTELRDFRD | SRRERSPDFT |
430 | 440 | 450 | 460 | 470 | 480 |
IFLCFGQCFS | STKPKESKLI | LVKLVPQFCE | YWYEQVQRGG | ASSLNSGNVS | LQLSDSFNLF |
490 | |||||
ELIEQYHMQT | D |